Neoventa Medical
Janna Klein is an accomplished professional with extensive experience in leadership and consulting roles. Currently serving as Chief Operating Officer at Neoventa Medical since April 2022, Janna previously worked as a Consultant at McKinsey & Company from March 2020 to March 2022. Prior to this, Janna held multiple positions at Sealand – A Maersk Company, including Transformation Partner and Senior Specialist from December 2017 to December 2019, and Client Coordinator at Seago Line from September 2014 to November 2017. Janna holds an MPhil in Development Studies with a focus on Development Economics and International Development from the University of Cambridge and a BSc in Global Studies, specializing in International Relations, from the University of Gothenburg. Additional educational experiences include studies at Hanoi University, Dublin City University, Universidad de Buenos Aires/Vestfold University College, and Lund University.
This person is not in any teams
This person is not in any offices
Neoventa Medical
Neoventa Medical AB is a Swedish medical device company founded in 1997 by Professor KG Rosén, Physiologist, Paediatrician & Neonatologist, trained at the University of Gothenburg, Sweden. Professor Rosén started Medical device developments, as a way to secure the use of his profound knowledge gained from experimental and clinical research inthe field of Fetal Monitoring.Neoventa provides innovative fetal monitoring solutions and services that improve obstetric care. Their solutions are designed to promote patient safety through enhanced decision support together with a structured workflow. Every day across the globe, health care professionals use their unique solutions to ensure a good start in life.Their core competence lies in using the STAN fetal monitor to perform evidence-based ST Analysis of the fetal ECG as an adjunct to CTG, “a second pair of eyes” during childbirth. They are also the provider of disposable fetal scalp electrodes for internal fetal monitoring under the brand Goldtrace. Another important area of business is a comprehensive education and training program, Neoventa Academy, which includes e-learning with certification.Numerous studies have shown that ST Analysis as an adjunct to CTG during labour reduces the number of babies born with risk of neurological damage, results in fewer operative deliveries, less need for fetal blood sampling and simultaneously being cost effective. The STAN fetal monitor has been used to deliver over one million children since its introduction in Europe. Over 15,000 patients have been enrolled in randomized trials and over 100,000 patients have been enrolled in observational studies.